Notice

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

Resources for Researchers

NIAID offers many resources to support your research, including reagents, model organisms, and tissue samples, to name just a few. Use the filters under Filter Search Results to narrow your search, or simply enter specific search terms in the search field.

We found 35 resources that match your search and filter choices.
Your selections:
Clear all

Show Filters

  • Preclinical Models of Infectious Disease

    Services are provided to study the full range of pathogens, including bacteria, viruses, parasites, fungi, and other agents such as toxins and prion proteins....

    coanstevensje@nih.gov - 2017-08-22 17:18

  • Biocontainment Laboratory: Colorado State University Infectious Disease Research Center

    The Colorado State University Regional Biocontainment Laboratory is one of the NIAID-supported Regional Biocontainment Laboratories. The Center provides a safe, secure, state of art facility for university investigators, government scientists and industry representatives to collaboratively research...

    coanstevensje@nih.gov - 2017-08-22 17:18

  • NIH AIDS Reagent Program

    The National Institutes of Health (NIH) AIDS Reagent Program provides critical research reagents and resources to the scientific community. The ARP acquires, develops, and produces state-of-the-art reagents and provides these reagents at no cost to qualified investigators throughout the world. The...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV Drug Formulation Development and Manufacturing Services

    This service program supports the development and manufacture, of a wide variety of pharmaceutical dosage formulations, including tablets, capsules, semi-solid preparations, injectibles, and sustained-release products. If requested, manufacturing can be done under GMP....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV/TB Drug Development: Chemical Synthesis

    This service provides chemical synthesis of lead compounds for use in additional drug development studies. Compounds must previously have been successfully synthesized to be candidates for this service. Synthesis of new analogs is not supported....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV Drug Development: Preclinical Pharmacology and Toxicology Services

    This service can be used to provide pharmacokinetic and safety assessments of products in mice, rats, rabbits, dogs, and nonhuman primates....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • HIV Drug Development: Analytical Chemistry Services

    This service can be used to develop and perform a variety of analytical assays to assess the properties of drug substances and their formulations....

    coanstevensje@nih.gov - 2017-08-28 15:27

  • Simian Vaccine Evaluation Units (SVEUs)

    The SVEU provides the nonhuman primates for studies to evaluate candidate SIV or HIV vaccines. The SVEU contractor will immunize nonhuman primates with the candidate vaccine and, together with the Nonhuman Primate (NHP) Immunology Laboratories, can evaluate humoral and cellular immune responses that...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • Comprehensive Resources for HIV Microbicides and Biomedical Prevention (CRMP)

    This contract provides gap-filling support services for HIV prevention drug developers including academic (investigators), for-profit and not-for-profit small and large companies, and other product innovators (henceforth identified as Sponsors) for the development of HIV non-vaccine biomedical...

    coanstevensje@nih.gov - 2017-08-28 15:27

  • ACTG Network Laboratory (ACTG NL)

    The ACTG NL consists of Core Laboratory groups in immunology, pharmacology, virology and TB. Each Core Laboratory Group is comprised of several Specialty Laboratories that provide a broad range of assays and services required to conduct the scientific agenda of the ACTG and to complement laboratory...

    coanstevensje@nih.gov - 2017-08-29 17:42

  • Biopharmaceutical Product Development Services

    Provides services to facilitate preclinical development of materials that are derived from biotechnology processes, such as: Monoclonal antibodies and derivatives of monoclonal antibodies Recombinant proteins Peptides Nucleic acid based vectors (siRNA, plasmids) Live, modified-live and/or attenuated...

    coanstevensje@nih.gov - 2017-08-29 17:42

  • In Vitro Assessment for Antimicrobial Activity Program

    The In Vitro Assessment for Antimicrobial Activity program tests antimicrobial activity of products against microbial pathogens and vectors, including those derived from clinical specimens....

    coanstevensje@nih.gov - 2017-08-30 12:45

  • Interventional Agent Development Services

    The Interventional Agent Development Services program provides services to facilitate preclinical development of therapeutics and new in vivo diagnostics for infectious disease-causing pathogens and/or toxins, such as imaging and skin test reagents. Note: Devices are excluded. Part of the...

    coanstevensje@nih.gov - 2017-08-30 12:45

  • HIV Drug Development: In Vivo Efficacy Evaluations

    This service provides evaluation of products in animal efficacy models. A product must demonstrate a potent and selective activity profile in vitro against the HIV strain used in the model prior to its acceptance as a candidate for this service. Studies to determine optimal routes and schedules of...

    coanstevensje@nih.gov - 2017-08-30 12:45

  • HIV Drug Development: In Vitro Efficacy Evaluations

    This service provides follow-up studies of products which already have been evaluated in a biochemical or cell-based assay and shown to possess an activity profile that warrants further development of the product as an HIV therapeutic....

    coanstevensje@nih.gov - 2017-08-30 12:45

  • Phase I Clinical Trial Units for Therapeutics

    The Phase I Clinical Trial Units for Therapeutics support the design, development, implementation, and conduct of Phase I clinical trials to assess safety, pharmacokinetics, and/or pharmacodynamics of licensed and investigational therapeutic products, including immunomodulatory agents and monoclonal...

    coanstevensje@nih.gov - 2017-08-30 19:13

  • Vaccine Development Services

    Vaccine Development Services is intended for use in the investigation, control, prevention, and treatment of a wide range of infectious agents other than HIV....

    coanstevensje@nih.gov - 2017-08-30 19:13

  • Vaccine and Treatment Evaluation Units (VTEUs) Services

    The Vaccine and Treatment Evaluation Units (VTEUs), supported by the Division of Microbiology and Infectious Diseases (DMID) since the 1960s, comprise a consortium of contracts with academic centers and organizations that provides a ready resource for the conduct of clinical trials to evaluate...

    coanstevensje@nih.gov - 2017-09-08 14:17

  • Biocontainment Laboratory: Duke University School of Medicine, Duke Human Vaccine Institute

    The Duke University School of Medicine, Duke Human Vaccine Institute (DHVI) Regional Biocontainment Lab (RBL) is one of the NIAID-supported Biocontainment Laboratories. The RBL supports basic research to develop drugs, diagnostics, and vaccines for emerging and reemerging infections and biodefense.

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Alabama at Birmingham Southeastern Biosafety Laboratory Alabama Birmingham (SEBLAB)

    The regional biocontainment laboratory at University of Alabama at Birmingham (UAB), called Southeastern Biosafety Laboratory Alabama Birmingham (SEBLAB), is one of the NIAID-supported Biocontainment Laboratories. The Lab houses state-of-the art biosafety level 2 and level 3 laboratories as well as...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Chicago Howard T. Ricketts Laboratory

    The University of Chicago Howard T. Ricketts Laboratory (HTRL) is one of the NIAID-supported Biocontainment Laboratories.  The HTRL is a state of the art BSL-3 facility constructed to support research on bacterial and viral pathogens. The Lab is registered with the US Select Agent Program and its...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Louisville Center for Predictive Medicine (CPM)

    The Regional Biocontainment Lab (RBL) at the Center for Predictive Medicine is one of the NIAID-supported Biocontainment Laboratories. The Lab provides a valuable national resource and asset to the University of Louisville, our region, and the greater scientific and public health communities. The...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Missouri Regional Laboratory for Infectious Disease Research (LIDR)

    The University of Missouri Laboratory for Infectious Disease Research (LIDR) is one of the NIAID-supported Biocontainment Laboratories. LIDR is a critical resource for University of Missouri faculty and collaborating scientists who perform research on infectious diseases and is part of our...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Pittsburgh

    The University of Pittsburgh Regional Biocontainment Laboratory is one of the NIAID-supported Biocontainment Laboratories. The Lab is a unique facility designed to support the research community and national biodefense network by providing state-of-the-art Biosafety Level 3 (BSL-3) and Animal...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Biocontainment Laboratory: University of Tennessee

    The University of Tennessee Regional Biocontainment Laboratory (RBL) is one of the NIAID-supported Biocontainment Laboratories. The RBL provides a secure lab for conducting research on Category A and B infectious pathogens using state-of-the-art molecular pathogenesis and immunologic approaches. The...

    coanstevensje@nih.gov - 2017-09-20 11:26

  • Resources to Evaluate New Technologies for Monitoring HIV-infected Patients

    Current methods for monitoring HIV-infected patients on antiretroviral therapy are expensive and technologically complex, making it difficult for use in resource-limited countries around the world. To advance the field, NIAID has resources available to assist investigators who wish to evaluate new...

    coanstevensje@nih.gov - 2017-09-27 13:04

  • Microbicide Trials Network (MTN) Resources

    The Microbicide Trials Network (MTN) is a NIAID-funded worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV. The MTN accepts concepts for new protocols, ancillary study proposals, secondary data analysis requests, and dataset requests....

    coanstevensje@nih.gov - 2017-09-27 14:05

  • Microbicides to Prevent HIV Transmission In Vitro

    This service provides evaluation of products that have already been evaluated in a biochemical or cell-based assay and shown to possess an activity profile that warrants further development as a microbicide. NIAID does NOT offer the primary screening of previously untested products via this service...

    coanstevensje@nih.gov - 2017-10-02 15:10

  • Biocontainment Laboratory: Boston University National Emerging Infectious Diseases Laboratory

    The National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national network of secure facilities studying infectious diseases that are—or have the potential to become—major public health concerns...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: George Mason University National Center for Biodefense and Infectious Diseases

    The George Mason University National Center for Biodefense and Infectious Diseases Biomedical Research Laboratory (BRL) is one of the NIAID-supported Biocontainment Laboratories. The RBL supports research programs in the National Center for Biodefense and Infectious Diseases focusing on host...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: Rutgers University

    The Rutgers University Regional Biocontainment Laboratory is one of the NIAID-supported Biocontainment Laboratories. The RBL is a highly secure facility designed to provide an ultra-safe work environment for scientists and support staff, as well as the public at large....

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: Tufts University

    The Tufts New England Regional Biosafety Laboratory (RBL) is one of the NIAID-supported Regional Biocontainment Laboratories. The RBL is a 41,000 square foot resource available to researchers in industry, academia, government and not-for-profit, dedicated to the study of existing and emerging...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: Tulane University

    The Tulane University Regional Biosafety Laboratory (RBL) at The Tulane National Primate Research Center is one of the NIAID-supported Biocontainment Laboratories. Research conducted in the facility focuses on the development of treatments, vaccines and diagnostics for emerging infectious diseases...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Biocontainment Laboratory: University of Texas Medical Branch Galveston National Laboratory

    As one of two National Biocontainment Laboratories constructed under grants awarded by the National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH), the Galveston National Laboratory (GNL) enables progress in our understanding of the fundamental mechanisms...

    coanstevensje@nih.gov - 2017-10-11 13:36

  • Therapeutic Development Services

    The Therapeutic Development Services program offers a collection of preclinical services to support the development of products intended for use in the cure, mitigation, diagnosis, or treatment of disease caused by a pathogen or certain toxins....

    coanstevensje@nih.gov - 2017-11-17 16:28